Over the past 12 months, 3 insiders at Tyra Biosciences, Inc. filed 14 open-market SEC Form 4 transactions on TYRA: 0 purchases worth $0 and 14 sales worth $10.6M. Insiders have been net sellers over this period. The most recent filing was on Mar 25, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 26 | Gilla KaplanDirector | SELL | 14.3K | $36.97 | $528K |
| Feb 12, 26 | Daniel BensenChief Discovery Officer | SELL | 5.9K | $33.37 | $196K |
| Jan 12, 26 | Daniel BensenChief Discovery Officer | SELL | 7.0K | $29.08 | $199K |
| Dec 19, 25 | Robert J MoreDirector | SELL | 10.0K | $25.00 | $250K |
| Dec 12, 25 | Daniel BensenChief Discovery Officer | SELL | 8.0K | $22.64 | $181K |
| Nov 21, 25 | Robert J MoreDirector | SELL | 246.9K | $20.25 | $5.0M |
| Nov 19, 25 | Daniel BensenChief Operating Officer | SELL | 50.0K | $16.32 | $815K |
| Nov 18, 25 | Daniel BensenChief Operating Officer | SELL | 75.6K | $16.07 | $1.2M |
| Nov 17, 25 | Daniel BensenChief Operating Officer | SELL | 18.6K | $17.07 | $299K |
| Nov 14, 25 | Daniel BensenChief Operating Officer | SELL | 110.2K | $16.02 | $1.8M |
| Nov 13, 25 | Daniel BensenChief Operating Officer | SELL | 1.1K | $16.00 | $18K |
| Jun 18, 25 | Gilla KaplanDirector | SELL | 9.6K | $9.78 | $94K |
| Jun 17, 25 | Gilla KaplanDirector | SELL | 10 | $10.35 | $104 |
| Jun 16, 25 | Gilla KaplanDirector | SELL | 6.8K | $10.38 | $71K |
| Jun 16, 25 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 11.8K | $10.13 | $120K |
| Jun 13, 25 | Gilla KaplanDirector | SELL | 15.0K | $10.31 | $155K |
| Jun 13, 25 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 120.2K | $10.20 | $1.2M |
| Jun 12, 25 | Gilla KaplanDirector | SELL | 30.0K | $10.31 | $309K |
| Jun 12, 25 | Ra Capital Management, L.p.Director,TenPercentOwner | BUY | 31.3K | $10.20 | $319K |
| Jun 9, 25 | Ra Capital Healthcare Fund LpDirector,TenPercentOwner | BUY | 186.8K | $10.19 | $1.9M |
| Jun 5, 25 | Peter KolchinskyDirector,TenPercentOwner | BUY | 213.3K | $10.04 | $2.1M |
| Jun 4, 25 | Peter KolchinskyDirector,TenPercentOwner | BUY | 997.9K | $9.63 | $9.6M |
| Feb 5, 25 | Nina S KjellsonDirector | SELL | 3.5K | $13.76 | $48K |
| Jan 23, 25 | Nina S KjellsonDirector | SELL | 4.8K | $16.26 | $78K |
| Jan 21, 25 | Nina S KjellsonDirector | SELL | 4.0K | $16.36 | $65K |
| Jan 17, 25 | Nina S KjellsonDirector | SELL | 12.8K | $16.40 | $210K |
| Jan 16, 25 | Nina S KjellsonDirector | SELL | 6.9K | $16.29 | $113K |
| Nov 25, 24 | Nina S KjellsonDirector | SELL | 4.7K | $16.84 | $79K |
| Nov 8, 24 | Ra Capital Healthcare Fund LpDirector,TenPercentOwner | BUY | 1.22M | $16.25 | $19.8M |
| Nov 7, 24 | Nina S KjellsonDirector | SELL | 19.7K | $17.32 | $342K |
| Nov 6, 24 | Nina S KjellsonDirector | SELL | 46.9K | $17.18 | $805K |
| Nov 5, 24 | Nina S KjellsonDirector | SELL | 9.4K | $16.77 | $157K |
| Nov 4, 24 | Nina S KjellsonDirector | SELL | 960 | $17.01 | $16K |
| Nov 1, 24 | Nina S KjellsonDirector | SELL | 23.9K | $17.16 | $396K |
| Oct 31, 24 | Nina S KjellsonDirector | SELL | 89.4K | $16.46 | $1.5M |
| Oct 30, 24 | Alan FuhrmanChief Financial Officer | BUY | 9.5K | $16.00 | $152K |
| Oct 30, 24 | Nina S KjellsonDirector | SELL | 9.9K | $16.17 | $160K |
| Oct 21, 24 | Todd HarrisPresident and CEO | SELL | 13.2K | $28.16 | $371K |
| Oct 18, 24 | Todd HarrisPresident and CEO | SELL | 43.6K | $27.01 | $1.2M |
| Oct 17, 24 | Todd HarrisPresident and CEO | SELL | 15.2K | $26.37 | $393K |
| Oct 16, 24 | Todd HarrisPresident and CEO | SELL | 24.5K | $26.98 | $642K |
| Oct 15, 24 | Todd HarrisPresident and CEO | SELL | 10.0K | $24.31 | $244K |
| Sep 30, 24 | Todd HarrisPresident and CEO | SELL | 500 | $24.00 | $12K |
| Sep 25, 24 | Todd HarrisPresident and CEO | SELL | 600 | $24.01 | $14K |
| Sep 24, 24 | Todd HarrisPresident and CEO | SELL | 1.1K | $24.02 | $25K |
| Sep 23, 24 | Todd HarrisPresident and CEO | SELL | 10.1K | $24.13 | $244K |
| Sep 20, 24 | Todd HarrisPresident and CEO | SELL | 7.1K | $24.19 | $172K |
| Sep 19, 24 | Todd HarrisPresident and CEO | SELL | 5.7K | $25.10 | $138K |
| Sep 18, 24 | Todd HarrisPresident and CEO | SELL | 3.5K | $24.00 | $84K |
| Jun 10, 24 | Daniel BensenChief Operating Officer | SELL | 3.5K | $20.00 | $70K |
Over the past 12 months, insiders at Tyra Biosciences, Inc. filed 0 open-market purchases worth $0 and 14 sales worth $10.6M on TYRA, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 25, 26.
The largest recent open-market TYRA insider purchase in our data was $19.8M by Ra Capital Healthcare Fund Lp, Director,TenPercentOwner, filed on Nov 8, 24.
3 different insiders at Tyra Biosciences, Inc. filed open-market SEC Form 4 transactions on TYRA over the last 12 months.
InsiderTape plots every TYRA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Tyra Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →